1.Hofer, M, Pagliusi, SR, Hohn, A, Leibrock, J, Barde, YA.Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J 1990;9: 2459–2464.
2.Baquet, ZC, Bickford, PC, Jones, KR.Brain-derived neurotrophic factor is required for the establishment of the proper number of dopaminergic neurons in the substantia nigra pars compacta. J Neurosci 2005;25:6251–6259.
3.Gorski, JA, Zeiler, SR, Tamowski, S, Jones, KR.Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 2003;23:6856–6865.
4.Morse, JK, Wiegand, SJ, Anderson, K et al. Brain-derived neurotrophic factor (BDNF) prevents the degeneration of medial septal cholinergic neurons following fimbria transection. J Neurosci 1993;13:4146–4156.
5.Lipsky, RH, Marini, AM.Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann N Y Acad Sci 2007;1122:130–143.
6.Tian, F, Marini, AM, Lipsky, RH.NMDA receptor activation induces differential epigenetic modification of BDNF promoters in hippocampal neurons. Amino Acids 2009.
7.Chen, ZY, Patel, PD, Sant, G, Meng, CX, Teng, KK, Hempstead, BL, Lee, FS.Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J Neurosci 2004; 24:4401–4411.
8.Egan, MF, Kojima, M, Callicott, JH et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257–269.
9.Sen, S, Nesse, RM, Stoltenberg, SF et al. A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 2003;28:397–401.
10.Sklar, P, Gabriel, SB, McInnis, MG et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry 2002;7:579–593.
11.Pezawas, L, Verchinski, BA, Mattay, VS et al. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. J Neurosci 2004; 24:10099–10102.
12.Hariri, AR, Goldberg, TE, Mattay, VS, Kolachana, BS, Callicott, JH, Egan, MF, Weinberger, DR.Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J Neurosci 2003;23:6690–6694.
13.Neves-Pereira, M, Mundo, E, Muglia, P, King, N, Macciardi, F, Kennedy, JL.The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am J Hum Genet 2002;71:651–655.
14.Agartz, I, Sedvall, GC, Terenius, L, Kulle, B, Frigessi, A, Hall, H, Jonsson, EG.BDNF gene variants and brain morphology in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006;141B:513–523.
15.Bueller, JA, Aftab, M, Sen, S, Gomez-Hassan, D, Burmeister, M, Zubieta, JK.BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biol Psychiatry 2006;59:812–815.
16.Szeszko, PR, Lipsky, R, Mentschel, C et al. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Mol Psychiatry 2005;10: 631–636.
17.Frodl, T, Schule, C, Schmitt, G et al. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Arch Gen Psychiatry 2007;64:410–416.
18.Nemoto, K, Ohnishi, T, Mori, T, Moriguchi, Y, Hashimoto, R, Asada, T, Kunugi, H.The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neurosci Lett 2006; 397:25–29.
19.Toro, R, Chupin, M, Garnero, L et al. Brain volumes and Val66Met polymorphism of the BDNF gene: local or global effects?. Brain Struct Funct 2009;213:501–509.
20.Gerdes, LU, Gerdes, C, Hansen, PS, Klausen, IC, Faergeman, O, Dyerberg, J.The apolipoprotein E polymorphism in Greenland Inuit in its global perspective. Hum Genet 1996;98:546–550.
21.Gerdes, LU, Klausen, IC, Sihm, I, Faergeman, O.Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet Epidemiol 1992;9:155–167.
22.Corbo, RM, Scacchi, R.Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty' allele? Ann Hum Genet 1999;63:301–310.
23.Beffert, U, Nematollah Farsian, F, Masiulis, I, Hammer, RE, Yoon, SO, Giehl, KM, Herz, J.ApoE receptor 2 controls neuronal survival in the adult brain. Curr Biol 2006; 16:2446–2452.
24.Beffert, U, Stolt, PC, Herz, J.Functions of lipoprotein receptors in neurons. J Lipid Res 2004;45:403–409.
25.Dong, LM, Weisgraber, KH.Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J Biol Chem 1996;271:19053–19057.
26.Morrow, JA, Hatters, DM, Lu, B, Hochtl, P, Oberg, KA, Rupp, B, Weisgraber, KH.Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease. J Biol Chem 2002;277:50380–50385.
27.Jiang, Q, Lee, CY, Mandrekar, S et al. ApoE promotes the proteolytic degradation of Abeta. Neuron 2008;58: 681–693.
28.Burggren, AC, Zeineh, MM, Ekstrom, AD, Braskie, MN, Thompson, PM, Small, GW, Bookheimer, SY.Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 2008;41:1177–1183.
29.Jak, AJ, Houston, WS, Nagel, BJ, Corey-Bloom, J, Bondi, MW.Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dement Geriatr Cogn Disord 2007;23: 382–389.
30.Lind, J, Larsson, A, Persson, J et al. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 2006;396:23–27.
31.Soininen, H, Partanen, K, Pitkanen, A et al. Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E epsilon 4 allele. Neurology 1995;45:391–392.
32.Tohgi, H, Takahashi, S, Kato, E et al. Reduced size of right hippocampus in 39- to 80-year-old normal subjects carrying the apolipoprotein E epsilon4 allele. Neurosci Lett 1997;236:21–24.
33.Wishart, HA, Saykin, AJ, McAllister, TW et al. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele. Neurology 2006;67:1221–1224.
34.Espeseth, T, Westlye, LT, Fjell, AM, Walhovd, KB, Rootwelt, H, Reinvang, I.Accelerated age-related cortical thinning in healthy carriers of apolipoprotein E epsilon 4. Neurobiol Aging 2008;29:329–340.
35.Shaw, P, Lerch, JP, Pruessner, JC et al. Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study. Lancet Neurol 2007;6:494–500.
36.Mondadori, CR, de Quervain, DJ, Buchmann, A et al. Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex 2007;17:1934–1947.
37.Bradley, KM, Bydder, GM, Budge, MM, Hajnal, JV, White, SJ, Ripley, BD, Smith, AD.Serial brain MRI at 3–6 month intervals as a surrogate marker for Alzheimer's disease. Br J Radiol 2002;75:506–513.
38.Carmichael, OT, Kuller, LH, Lopez, OL et al. Ventricular volume and dementia progression in the Cardiovascular Health Study. Neurobiol Aging 2007;28:389–397.
39.Jack, CR Jr,
Shiung, MM, Gunter, JL et al. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004;62:591–600.
40.Thompson, PM, Hayashi, KM, De Zubicaray, GI et al. Mapping hippocampal and ventricular change in Alzheimer disease. Neuroimage 2004;22:1754–1766.
41.Wang, D, Chalk, JB, Rose, SE et al. MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging. Magn Reson Imaging 2002;20:41–48.
42.Ferrarini, L, Palm, WM, Olofsen, H, van Buchem, MA, Reiber, JH, Admiraal-Behloul, F.Shape differences of the brain ventricles in Alzheimer's disease. Neuroimage 2006;32:1060–1069.
43.Giesel, FL, Hahn, HK, Thomann, PA et al. Temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessment. AJNR Am J Neuroradiol 2006;27:1454–1458.
44.Shen, D, Davatzikos, C.HAMMER: hierarchical attribute matching mechanism for elastic registration. IEEE Trans Med Imaging 2002;21:1421–1439.
45.Smith, SM.Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–155.
46.Zhang, Y, Brady, M, Smith, S.Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001;20:45–57.
47.Rorden, C, Brett, M.Stereotaxic display of brain lesions. Behav Neurol 2000;12:191–200.
48.Richter-Schmidinger, T, Alexopoulos, P, Horn, M, Maus, S et al. Influence of Brain-derived neurotrophic factor and Apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J Neural Transm 2011;118:249–257.
49.Van Hoesen, GW, Parvizi, J, Chu, CC.Orbitofrontal cortex pathology in Alzheimer's disease. Cereb Cortex 2000;10: 243–251.
50.Ongur, D, Ferry, AT, Price, JL.Architectonic subdivision of the human orbital and medial prefrontal cortex. J Comp Neurol 2003;460:425–449.
51.Debette, S, Wolf, PA, Beiser, A et al. Association of parental dementia with cognitive and brain MRI measures in middle-aged adults. Neurology 2009;73:2071–2078.
52.Scarmeas, N, Habeck, CG, Hilton, J, Anderson, KE, Flynn, J, Park, A, Stern, Y.APOE related alterations in cerebral activation even at college age. J Neurol Neurosurg Psychiatry 2005;76:1440–1444.
53.Jack, CR Jr.Petersen, RC, Xu, YC et al. Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol 1998;43:303–310.
54.Reiman, EM, Uecker, A, Caselli, RJ et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol 1998;44:288–291.
55.Schmidt, H, Schmidt, R, Fazekas, F, Semmler, J, Kapeller, P, Reinhart, B, Kostner, GM.Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet 1996;50:293–299.
56.Geuze, E, Vermetten, E, Bremner, JD.MR-based in vivo hippocampal volumetrics: 1. Review of methodologies currently employed. Mol Psychiatry 2005;10:147–159.
57.Miyajima, F, Quinn, JP, Horan, M, Pickles, A, Ollier, WE, Pendleton, N, Payton, A.Additive effect of BDNF and REST polymorphisms is associated with improved general cognitive ability. Genes Brain Behav 2008;7:714–719.